Manhattan Scientifics, Inc. (MHTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 316 Thousand USD | -69.35% |
| 2022 | 1.03 Million USD | -70.15% |
| 2021 | 3.45 Million USD | -49.56% |
| 2020 | 6.84 Million USD | 207.78% |
| 2019 | 2.22 Million USD | -16.35% |
| 2018 | 2.66 Million USD | -75.47% |
| 2017 | 10.84 Million USD | 42.06% |
| 2016 | 7.63 Million USD | -40.67% |
| 2015 | 12.86 Million USD | 254.23% |
| 2014 | 3.63 Million USD | 95.22% |
| 2013 | 1.86 Million USD | 0.43% |
| 2012 | 1.85 Million USD | -11.97% |
| 2011 | 2.1 Million USD | 9.24% |
| 2010 | 1.92 Million USD | 116.52% |
| 2009 | 890 Thousand USD | -12.66% |
| 2008 | 1.01 Million USD | 41.14% |
| 2007 | 722 Thousand USD | 21.55% |
| 2006 | 594 Thousand USD | -49.23% |
| 2005 | 1.17 Million USD | -10.21% |
| 2004 | 1.3 Million USD | 6.37% |
| 2003 | 1.22 Million USD | -25.58% |
| 2002 | 1.64 Million USD | -43.18% |
| 2001 | 2.89 Million USD | -21.36% |
| 2000 | 3.68 Million USD | -1.23% |
| 1999 | 3.73 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 91 Thousand USD | -71.2% |
| 2024 Q2 | 74 Thousand USD | -18.68% |
| 2023 Q3 | 432 Thousand USD | -24.08% |
| 2023 Q1 | 694 Thousand USD | -32.69% |
| 2023 Q2 | 569 Thousand USD | -18.01% |
| 2023 Q4 | 316 Thousand USD | -26.85% |
| 2023 FY | 316 Thousand USD | -69.35% |
| 2022 Q1 | 2.88 Million USD | -16.36% |
| 2022 FY | 1.03 Million USD | -70.15% |
| 2022 Q3 | 1.36 Million USD | 0.0% |
| 2022 Q4 | 1.03 Million USD | -24.41% |
| 2022 Q2 | 1.36 Million USD | -52.79% |
| 2021 Q4 | 3.45 Million USD | -0.92% |
| 2021 Q1 | 7.08 Million USD | 3.39% |
| 2021 Q2 | 4.55 Million USD | -35.66% |
| 2021 Q3 | 3.48 Million USD | -23.47% |
| 2021 FY | 3.45 Million USD | -49.56% |
| 2020 Q2 | 2.15 Million USD | 36.33% |
| 2020 FY | 6.84 Million USD | 207.78% |
| 2020 Q1 | 1.57 Million USD | -29.12% |
| 2020 Q4 | 6.84 Million USD | 70.18% |
| 2020 Q3 | 4.02 Million USD | 87.16% |
| 2019 Q3 | 3.17 Million USD | 69.6% |
| 2019 Q2 | 1.87 Million USD | -22.06% |
| 2019 Q1 | 2.4 Million USD | -9.7% |
| 2019 FY | 2.22 Million USD | -16.35% |
| 2019 Q4 | 2.22 Million USD | -29.92% |
| 2018 Q1 | 8.05 Million USD | -25.71% |
| 2018 FY | 2.66 Million USD | -75.47% |
| 2018 Q3 | 6.24 Million USD | -10.32% |
| 2018 Q4 | 2.66 Million USD | -57.42% |
| 2018 Q2 | 6.96 Million USD | -13.55% |
| 2017 FY | 10.84 Million USD | 42.06% |
| 2017 Q4 | 10.84 Million USD | -25.63% |
| 2017 Q2 | 15.28 Million USD | 68.83% |
| 2017 Q1 | 9.05 Million USD | 18.57% |
| 2017 Q3 | 14.58 Million USD | -4.58% |
| 2016 Q1 | 11.19 Million USD | -13.05% |
| 2016 Q3 | 8.53 Million USD | -10.32% |
| 2016 Q4 | 7.63 Million USD | -10.51% |
| 2016 FY | 7.63 Million USD | -40.67% |
| 2016 Q2 | 9.51 Million USD | -14.98% |
| 2015 Q3 | 14.23 Million USD | -11.23% |
| 2015 Q2 | 16.03 Million USD | -9.0% |
| 2015 Q1 | 17.61 Million USD | 384.94% |
| 2015 Q4 | 12.86 Million USD | -9.57% |
| 2015 FY | 12.86 Million USD | 254.23% |
| 2014 FY | 3.63 Million USD | 95.22% |
| 2014 Q1 | 3.16 Million USD | 69.8% |
| 2014 Q2 | 2.93 Million USD | -7.22% |
| 2014 Q3 | 2.35 Million USD | -19.68% |
| 2014 Q4 | 3.63 Million USD | 54.27% |
| 2013 FY | 1.86 Million USD | 0.43% |
| 2013 Q3 | 2.07 Million USD | -16.73% |
| 2013 Q4 | 1.86 Million USD | -10.14% |
| 2013 Q2 | 2.48 Million USD | 18.94% |
| 2013 Q1 | 2.09 Million USD | 12.84% |
| 2012 Q4 | 1.85 Million USD | -10.35% |
| 2012 Q3 | 2.06 Million USD | -6.26% |
| 2012 Q2 | 2.2 Million USD | -6.84% |
| 2012 Q1 | 2.36 Million USD | 12.45% |
| 2012 FY | 1.85 Million USD | -11.97% |
| 2011 Q4 | 2.1 Million USD | 2.93% |
| 2011 Q2 | 2.53 Million USD | 23.93% |
| 2011 Q1 | 2.04 Million USD | 6.28% |
| 2011 FY | 2.1 Million USD | 9.24% |
| 2011 Q3 | 2.04 Million USD | -19.42% |
| 2010 Q2 | 779 Thousand USD | -30.38% |
| 2010 Q4 | 1.92 Million USD | 169.89% |
| 2010 Q3 | 714 Thousand USD | -8.34% |
| 2010 FY | 1.92 Million USD | 116.52% |
| 2010 Q1 | 1.11 Million USD | 25.73% |
| 2009 Q4 | 890 Thousand USD | -22.0% |
| 2009 FY | 890 Thousand USD | -12.66% |
| 2009 Q1 | 815 Thousand USD | -20.02% |
| 2009 Q2 | 912 Thousand USD | 11.9% |
| 2009 Q3 | 1.14 Million USD | 25.11% |
| 2008 Q3 | 1.3 Million USD | 4.16% |
| 2008 Q2 | 1.25 Million USD | 161.17% |
| 2008 FY | 1.01 Million USD | 41.14% |
| 2008 Q1 | 479 Thousand USD | -33.66% |
| 2008 Q4 | 1.01 Million USD | -21.8% |
| 2007 Q1 | 511 Thousand USD | -13.97% |
| 2007 FY | 722 Thousand USD | 21.55% |
| 2007 Q4 | 722 Thousand USD | -39.53% |
| 2007 Q3 | 1.19 Million USD | -6.28% |
| 2007 Q2 | 1.27 Million USD | 149.32% |
| 2006 Q3 | 728 Thousand USD | -10.12% |
| 2006 Q4 | 594 Thousand USD | -18.41% |
| 2006 Q1 | 953 Thousand USD | -18.55% |
| 2006 Q2 | 810 Thousand USD | -15.01% |
| 2006 FY | 594 Thousand USD | -49.23% |
| 2005 Q1 | 1.27 Million USD | -2.0% |
| 2005 Q2 | 1.14 Million USD | -10.57% |
| 2005 FY | 1.17 Million USD | -10.21% |
| 2005 Q3 | 1.11 Million USD | -2.71% |
| 2005 Q4 | 1.17 Million USD | 5.31% |
| 2004 FY | 1.3 Million USD | 6.37% |
| 2004 Q3 | 1.42 Million USD | -11.14% |
| 2004 Q2 | 1.59 Million USD | 38.84% |
| 2004 Q1 | 1.15 Million USD | -6.04% |
| 2004 Q4 | 1.3 Million USD | -8.24% |
| 2003 Q1 | 1.37 Million USD | -16.65% |
| 2003 Q2 | 1.39 Million USD | 1.97% |
| 2003 FY | 1.22 Million USD | -25.58% |
| 2003 Q4 | 1.22 Million USD | -7.62% |
| 2003 Q3 | 1.32 Million USD | -5.22% |
| 2002 FY | 1.64 Million USD | -43.18% |
| 2002 Q1 | 2.68 Million USD | -7.28% |
| 2002 Q2 | 2.37 Million USD | -11.58% |
| 2002 Q3 | 2.29 Million USD | -3.54% |
| 2002 Q4 | 1.64 Million USD | -28.15% |
| 2001 Q4 | 2.89 Million USD | -12.53% |
| 2001 Q3 | 3.31 Million USD | -7.85% |
| 2001 Q1 | 2.79 Million USD | -24.19% |
| 2001 FY | 2.89 Million USD | -21.36% |
| 2001 Q2 | 3.59 Million USD | 28.68% |
| 2000 Q2 | 3.37 Million USD | 8.88% |
| 2000 Q4 | 3.68 Million USD | 35.69% |
| 2000 Q3 | 2.71 Million USD | -19.46% |
| 2000 Q1 | 3.09 Million USD | 0.0% |
| 2000 FY | 3.68 Million USD | -1.23% |
| 1999 FY | 3.73 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Avitar, Inc. | 1.74 Million USD | 81.92% |
| BioElectronics Corporation | 144.38 Thousand USD | -118.855% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 999 Thousand USD | 68.368% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | 63.71% |
| Polarean Imaging plc | 10.86 Million USD | 97.092% |
| AVITA Medical, Inc. | 144.33 Million USD | 99.781% |
| Össur hf. | 1.39 Billion USD | 99.977% |
| Zecotek Photonics Inc. | 2.57 Million USD | 87.718% |
| QHSLab, Inc. | 1.68 Million USD | 81.206% |
| Wellstar International, Inc. | 957.89 Thousand USD | 67.011% |
| Össur hf. | 1.39 Billion USD | 99.977% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 99.693% |
| Escalon Medical Corp. | 4.75 Million USD | 93.358% |
| Aurora Spine Corporation | 11.92 Million USD | 97.35% |
| BrainsWay Ltd. | 62.97 Million USD | 99.498% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.85 Million USD | 88.924% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 99.713% |
| Vivos Inc. | 1.61 Million USD | 80.374% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 99.992% |
| Kelyniam Global, Inc. | 1.63 Million USD | 80.645% |
| REMSleep Holdings, Inc. | 1.2 Million USD | 73.804% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -477.19% |
| Nanomix Corporation | 982.05 Thousand USD | 67.823% |
| Theraclion SA | 18.66 Million EUR | 98.307% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -73.455% |
| Positron Corporation | 1.76 Million USD | 82.123% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | 57.776% |
| Lombard Medical, Inc. | 67.76 Million USD | 99.534% |
| ALR Technologies Inc. | 193.21 Thousand USD | -63.547% |
| Stratec SE | 529.71 Million USD | 99.94% |
| Vycor Medical, Inc. | 992.29 Thousand USD | 68.155% |
| Heart Tronics, Inc. | 4.04 Million USD | 92.195% |
| Nu-Med Plus, Inc. | 2.21 Million USD | 85.715% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 98.462% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 98.59% |
| VMS Rehab Systems, Inc. | 4.45 USD | -7101023.596% |
| Guided Therapeutics, Inc. | 1.66 Million USD | 81.067% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | 57.166% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | 30.67% |
| United American Healthcare Corporation | 10.37 Million USD | 96.955% |
| ECGI Holdings, Inc. | 5.2 Million USD | 93.925% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -835.077% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | 85.225% |
| Urologix, Inc. | 5.66 Million USD | 94.424% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | 85.984% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 98.447% |
| SS Innovations International, Inc. | 25.47 Million USD | 98.76% |
| Qualis Innovations, Inc. | 2431.00 USD | -12898.766% |
| Smith & Nephew plc | 9.97 Billion USD | 99.997% |
| NIOX Group Plc | 116.47 Million USD | 99.729% |
| Fuse Medical, Inc. | 16.25 Million USD | 98.056% |
| Broncus Holding Corporation | 195.75 Million USD | 99.839% |
| Brain Scientific Inc. | 11.74 Million USD | 97.309% |
| Pressure BioSciences, Inc. | 1.04 Million USD | 69.895% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -999.704% |